141 related articles for article (PubMed ID: 6450255)
1. Abnormalities of T lymphocyte subsets in patients with progressive systemic sclerosis (PSS, scleroderma).
Inoshita T; Whiteside TL; Rodnan GP; Taylor FH
J Lab Clin Med; 1981 Feb; 97(2):264-77. PubMed ID: 6450255
[TBL] [Abstract][Full Text] [Related]
2. Human postthymic precursor cells in health and disease. VII. Immunoregulatory circuits of the peripheral blood mononuclear cells from patients with progressive systemic sclerosis.
Alarcón-Segovia D; Palacios R; Ibáñez de Kasep G
J Clin Lab Immunol; 1981 May; 5(3):143-8. PubMed ID: 6453999
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities of immunoregulation in progressive systemic sclerosis. Evidence for excess helper-cell function and altered B-cell function.
Krakauer RS; Sundeen J; Sauder DN; Scherbel A
Arch Dermatol; 1981 Feb; 117(2):80-2. PubMed ID: 6451199
[TBL] [Abstract][Full Text] [Related]
4. Subpopulations of human T lymphocytes. IX. Imbalance of T cell subpopulations in patients with progressive systemic sclerosis.
Gupta S; Malaviya AN; Rajagopalan P; Good RA
Clin Exp Immunol; 1979 Nov; 38(2):342-7. PubMed ID: 316754
[TBL] [Abstract][Full Text] [Related]
5. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
Moutsopoulos HM; Fauci AS
J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte subpopulations and reactivity to mitogens in patients with scleroderma.
Baron M; Keystone EC; Gladman DD; Lee P; Poplonski L
Clin Exp Immunol; 1981 Oct; 46(1):70-6. PubMed ID: 6978216
[TBL] [Abstract][Full Text] [Related]
7. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
[TBL] [Abstract][Full Text] [Related]
8. T-lymphocyte subpopulations in rheumatoid arthritis. II. Definition by monoclonal antibodies.
Pfreundschuh M; Michel H; Parino G; Gram N; Stock C; Gause A; Hunstein W
Z Rheumatol; 1981; 40(6):245-9. PubMed ID: 6460396
[TBL] [Abstract][Full Text] [Related]
9. Suppressor T cells in mycosis fungoides and so-called premycotic eruptions.
Wassermann J; Biberfeld G; Baral E; Blomgren H; Thyresson N; Brehmer-Andersson E
Acta Derm Venereol; 1980; 60(2):139-43. PubMed ID: 6155020
[TBL] [Abstract][Full Text] [Related]
10. [Separation and characterization of human T G and T M lymphocyte populations].
Mariani E; Mariani AR; Mazzetti M; Mazzoli M; Baraldini M; Facchini A; Stefanini GF
Boll Soc Ital Biol Sper; 1980 Aug; 56(15):1590-6. PubMed ID: 6970041
[TBL] [Abstract][Full Text] [Related]
11. T lymphocyte subpopulations in progressive systemic sclerosis defined by monoclonal antibodies.
Czirják L; Surányi P; Dankó K; Szegedi G
Acta Med Hung; 1985; 42(3-4):129-32. PubMed ID: 3879347
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of lymphocytes and T-cell subsets in patients with disseminated cancer.
Cobleigh MA; Braun DP; Harris JE
J Natl Cancer Inst; 1980 May; 64(5):1041-5. PubMed ID: 6966003
[TBL] [Abstract][Full Text] [Related]
13. Circulating T and B lymphocytes in progressive systemic sclerosis.
de Jesus DG; Clancy RL
J Rheumatol; 1975 Sep; 2(3):336-9. PubMed ID: 1081143
[TBL] [Abstract][Full Text] [Related]
14. The presence of dominant T-cell clones in peripheral blood of patients with collagen vascular disorders: a prospective study of 97 cases.
Dereure O; Gubler B; Bessis D; Guillot B; Guilhou JJ; Clot J; Eliaou JF
Br J Dermatol; 2006 Mar; 154(3):445-9. PubMed ID: 16445773
[TBL] [Abstract][Full Text] [Related]
15. Imbalances in peripheral blood T-cell subpopulations in renal transplant patients.
Luciani G; Maggiano N; Citterio F; Lauriola L; Pozzetto U; Piantelli M; Castagneto M; Musiani P
Clin Exp Immunol; 1981 Dec; 46(3):615-20. PubMed ID: 7039895
[TBL] [Abstract][Full Text] [Related]
16. Blood lymphocyte subpopulations in Mycosis fungoides and their functions in vitro.
Gu SQ; Petrini B; von Stedingk LV; Thyresson N; Wasserman J
Acta Derm Venereol; 1981; 61(6):487-90. PubMed ID: 6177158
[TBL] [Abstract][Full Text] [Related]
17. T lymphocyte subset abnormalities and HLA antigens in scleroderma (systemic sclerosis).
Barnett AJ; Tait BD; Barnett MA; Toh BH
Clin Exp Immunol; 1989 Apr; 76(1):24-9. PubMed ID: 2525437
[TBL] [Abstract][Full Text] [Related]
18. T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome.
Li X; Li X; Qian L; Wang G; Zhang H; Wang X; Chen K; Zhai Z; Li Q; Wang Y; Harris DC
J Rheumatol; 2007 Dec; 34(12):2438-45. PubMed ID: 18050367
[TBL] [Abstract][Full Text] [Related]
19. Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis.
Riccieri V; Parisi G; Spadaro A; Scrivo R; Barone F; Moretti T; Bernardini G; Strom R; Taccari E; Valesini G
J Rheumatol; 2005 Feb; 32(2):283-6. PubMed ID: 15693088
[TBL] [Abstract][Full Text] [Related]
20. Impaired primary in-vitro antibody response in progressive systemic sclerosis patients: rôle of suppressor monocytes.
Segond P; Salliere D; Galanaud P; Desmottes RM; Massias P; Fiessinger JN
Clin Exp Immunol; 1982 Jan; 47(1):147-54. PubMed ID: 6212171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
